Latest News
|
15 January 2013
0 Likes 
The European Medicines Agency (EMA) has released an updated scientific guideline it says will make it easier for sponsors of oncology and other anticancer medicines to conduct clinical trials.The
Read More...
Latest News
Regulatory Update
|
18 December 2012
0 Likes
The UK’s cost containment agency, the National Institute for health and Clinical Excellence (NICE), has issued draft guidance saying that while Roche’s blockbuster cancer drug Avastin (bevacizumab)
Read More...
Latest News
|
3 December 2012
0 Likes
The US Food and Drug Administration (FDA) has released the final version of a long-awaited guidance on positron emission tomography (PET) drugs, nearly 10 months after first releasing the draft
Read More...
Latest News
|
4 September 2012
0 Likes
A new drug manufactured by California-based Astellas Pharma promises to help treat aggressive, late-stage prostate cancer that has evaded other treatments, the US Food and Drug Administration (FDA)
Read More...
Latest News
|
7 August 2012
0 Likes
The US Food and Drug Administration (FDA) is calling for the submission of pharmaceutical and biological products worthy of being brought before its Pediatric Subcommittee of the Oncologic Drugs
Read More...
Latest News
|
5 June 2012
0 Likes
Could 2012 be the year a long-running drought in product approvals and availability finally ends? The US Food and Drug Administration (FDA) is of the opinion that it might just be—if only for oncology
Read More...
Latest News
|
5 June 2012
0 Likes
A study presented at the American Society of Clinical Oncology (ASCO) 2012 meeting in Chicago finds there is a strong positive correlation between the amount of money a patient makes and how likely
Read More...
Latest News
|
9 May 2012
0 Likes
A new report published jointly by the California Healthcare Institute (CHI) and the Boston Consulting Group (BCG) is claiming the US Food and Drug Administration (FDA) is taking longer to approve
Read More...
Latest News
|
12 April 2012
0 Likes
Manufacturers of positron emission tomography (PET) drugs have until 12 June 2012 to comply with new regulations posted by the US Food and Drug Administration (FDA) on 10 April, reports In-Pharma
Read More...
Latest News
|
10 April 2012
0 Likes
The US Food and Drug Administration (FDA) is releasing a final guidance on positron emission tomography (PET) products to help manufacturers of the drugs meet the agency’s requirements for good
Read More...